Yuan Xue

1.8k total citations
58 papers, 1.1k citations indexed

About

Yuan Xue is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuan Xue has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 19 papers in Hepatology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuan Xue's work include Liver Disease Diagnosis and Treatment (14 papers), Hepatitis B Virus Studies (12 papers) and COVID-19 Clinical Research Studies (8 papers). Yuan Xue is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Hepatitis B Virus Studies (12 papers) and COVID-19 Clinical Research Studies (8 papers). Yuan Xue collaborates with scholars based in China, Sweden and United States. Yuan Xue's co-authors include Cong Chen, Tianmin Xu, Zhen Zhu, Jianchun Lu, Gang Yang, Zhaohui Lu, Chaoyang Tong, Guorong Gu, Manman Cui and Chunhua Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Yuan Xue

50 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan Xue China 15 619 323 204 188 133 58 1.1k
William Reiss United States 15 641 1.0× 463 1.4× 117 0.6× 210 1.1× 141 1.1× 37 1.5k
Zhihui Wang China 16 501 0.8× 206 0.6× 157 0.8× 358 1.9× 114 0.9× 47 1.3k
Zhixiong Wu China 17 253 0.4× 137 0.4× 112 0.5× 212 1.1× 119 0.9× 39 907
Cheng Tian China 10 563 0.9× 285 0.9× 224 1.1× 136 0.7× 28 0.2× 34 913
Fengchun Zhang China 15 748 1.2× 407 1.3× 146 0.7× 315 1.7× 303 2.3× 63 1.7k
Joyce Zhou United States 18 518 0.8× 220 0.7× 170 0.8× 325 1.7× 87 0.7× 37 1.5k
Tielong Chen China 13 613 1.0× 339 1.0× 140 0.7× 149 0.8× 81 0.6× 43 1.1k
Shanea K. Estes United States 13 326 0.5× 168 0.5× 97 0.5× 268 1.4× 64 0.5× 21 913
Guyi Wang China 15 399 0.6× 167 0.5× 152 0.7× 119 0.6× 81 0.6× 32 732
Bingzi Dong China 15 213 0.3× 111 0.3× 142 0.7× 384 2.0× 98 0.7× 63 1.1k

Countries citing papers authored by Yuan Xue

Since Specialization
Citations

This map shows the geographic impact of Yuan Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Xue more than expected).

Fields of papers citing papers by Yuan Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Xue. The network helps show where Yuan Xue may publish in the future.

Co-authorship network of co-authors of Yuan Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Xue. A scholar is included among the top collaborators of Yuan Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Xue. Yuan Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wang, Yuting, Bilin Tao, Xinling Shi, et al.. (2024). The impact of diabetes mellitus on tuberculosis recurrence in Eastern China: a retrospective cohort study. BMC Public Health. 24(1). 2534–2534.
4.
Zheng, Shuqin, et al.. (2024). Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis. Journal of Hepatocellular Carcinoma. Volume 11. 737–746. 3 indexed citations
5.
6.
7.
Xue, Yuan, Xiaotong Ma, Yuanyuan Zhao, et al.. (2023). Association between atherogenic index of plasma and asymptomatic intracranial arterial stenosis in middle-aged and elderly women: A cross-sectional study in Shandong, China. Nutrition Metabolism and Cardiovascular Diseases. 34(3). 598–605. 4 indexed citations
8.
9.
Yan, Peng, Xiang Wang, Yuanyuan Zhao, et al.. (2022). A retrospective study of drug-coated balloon angioplasty for vertebral artery origin stenosis. Neuroradiology. 64(8). 1617–1625. 1 indexed citations
10.
Liu, Longgen, et al.. (2022). Presence of Serum Antinuclear Antibodies Does Not Impact Outcomes in HBV-Related Acute-on-Chronic Liver Failure. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–6. 2 indexed citations
11.
Zhang, Xiujun, et al.. (2022). SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose. Virology Journal. 19(1). 148–148. 3 indexed citations
12.
Xiang, Yuanyuan, Lei Li, Xiaotong Ma, et al.. (2021). Recreational Nitrous Oxide Abuse: Prevalence, Neurotoxicity, and Treatment. Neurotoxicity Research. 39(3). 975–985. 61 indexed citations
13.
Zhu, Zhen, Zhaohui Lu, Tianmin Xu, et al.. (2020). Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19. Journal of Infection. 81(1). e21–e23. 304 indexed citations
14.
Sun, Qinjian, Qiuting Wang, Xinhua Wang, et al.. (2019). Prevalence and cardiovascular risk factors of asymptomatic intracranial arterial stenosis: the Kongcun Town Study in Shandong, China. European Journal of Neurology. 27(4). 729–735. 23 indexed citations
15.
Liu, Longgen, et al.. (2019). Plasma transfusion combined with chelating therapy alleviates fulminant Wilson's disease with a single Arg778Leu heterozygote mutation. Annals of Hepatology. 18(2). 393–396. 2 indexed citations
16.
Lu, Jianchun, Longgen Liu, Lin Lin, Shuqin Zheng, & Yuan Xue. (2018). Incident hepatocellular carcinoma developing during tenofovir alafenamide treatment as a rescue therapy for multi-drug resistant hepatitis B virus infection: A case report and review of the literature. World Journal of Clinical Cases. 6(13). 671–674. 6 indexed citations
17.
Lu, Jianchun, Lin Lin, Chunyan Ye, et al.. (2018). Serum NGAL Is Superior to Cystatin C in Predicting the Prognosis of Acute-on-Chronic Liver Failure. Annals of Hepatology. 18(1). 155–164. 15 indexed citations
18.
Xue, Yuan, et al.. (2017). Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma. Journal of International Medical Research. 45(4). 1310–1317. 15 indexed citations
19.
Liu, Longgen, Lin Lin, Jianchun Lu, et al.. (2017). Gamma-glutamyl transpeptidase-to-platelet ratio predicts the prognosis in HBV-associated acute-on-chronic liver failure. Clinica Chimica Acta. 476. 92–97. 14 indexed citations
20.
Yao, Chenling, Guorong Gu, Yuan Xue, et al.. (2016). Analysis of clinical features and prognosis analysis of 580 cases with aortic dissection. Zhonghua jizhen yixue zazhi. 25(5). 644–649.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Reiss Breakdown of academic impact, for papers by Zhihui Wang Breakdown of academic impact, for papers by Zhixiong Wu Breakdown of academic impact, for papers by Cheng Tian Breakdown of academic impact, for papers by Fengchun Zhang Breakdown of academic impact, for papers by Joyce Zhou Breakdown of academic impact, for papers by Tielong Chen Breakdown of academic impact, for papers by Shanea K. Estes Breakdown of academic impact, for papers by Guyi Wang Breakdown of academic impact, for papers by Bingzi Dong
Rankless by CCL
2026